We are live on ! Find out more
ACA

Aptus Capital Advisors Portfolio holdings

AUM $12.7B
1-Year Est. Return 17.41%
This Fund
S&P 500
This Quarter Est. Return
+3.67%
1 Year Est. Return
+17.41%
3 Year Est. Return
+53.41%
5 Year Est. Return
+57.81%
10 Year Est. Return
AUM
$711M
AUM Growth
+$125M
Cap. Flow
+$103M
Cap. Flow %
14.44%
Top 10 Hldgs %
45.18%
Holding
372
New
65
Increased
147
Reduced
95
Closed
43

Top Sells

Rank Stock Value
1
WAT icon
Waters Corp
WAT
+$2.96M
2
A icon
Agilent Technologies
A
+$2.86M
3
ORLY icon
O'Reilly Automotive
ORLY
+$2.82M
4
VST icon
Vistra
VST
+$2.73M
5
BSX icon
Boston Scientific
BSX
+$2.64M

Sector Composition

Rank Sector Weight
1 Technology 5.98%
2 Healthcare 5.26%
3 Consumer Discretionary 4.96%
4 Financials 4.37%
5 Industrials 3.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
26
Apple
AAPL
$4.9T
$3.14M 0.44%
63,468
+672
+1% +$32.7K
NOW icon
27
ServiceNow
NOW
$106B
$3.03M 0.43%
55,120
-3,510
-6% -$184K
CPRT icon
28
Copart
CPRT
$25.6B
$3.02M 0.42%
+161,492
New +$2.77M
KEYS icon
29
Keysight
KEYS
$54B
$2.96M 0.42%
32,914
-2,225
-6% -$189K
MDLZ icon
30
Mondelez International
MDLZ
$78.3B
$2.89M 0.41%
53,604
-4,280
-7% -$222K
AON icon
31
Aon
AON
$78.4B
$2.89M 0.41%
14,959
-1,104
-7% -$200K
ABT icon
32
Abbott
ABT
$175B
$2.87M 0.4%
34,145
-2,519
-7% -$198K
WTW icon
33
Willis Towers Watson
WTW
$27.7B
$2.87M 0.4%
14,965
-1,101
-7% -$199K
TDG icon
34
TransDigm Group
TDG
$67.9B
$2.86M 0.4%
5,906
-475
-7% -$222K
APD icon
35
Air Products & Chemicals
APD
$65.8B
$2.85M 0.4%
+12,600
New +$2.61M
XRAY icon
36
Dentsply Sirona
XRAY
$2.81B
$2.84M 0.4%
+48,654
New +$2.61M
TSN icon
37
Tyson Foods
TSN
$20.3B
$2.83M 0.4%
+35,077
New +$2.7M
LDOS icon
38
Leidos
LDOS
$13.4B
$2.75M 0.39%
+34,513
New +$2.52M
ES icon
39
Eversource Energy
ES
$28.1B
$2.73M 0.38%
36,040
-3,118
-8% -$228K
EW icon
40
Edwards Lifesciences
EW
$49.4B
$2.7M 0.38%
+43,914
New +$2.66M
AVGO icon
41
Broadcom
AVGO
$1.76T
$2.62M 0.37%
91,010
-7,490
-8% -$218K
ADSK icon
42
Autodesk
ADSK
$46.1B
$2.6M 0.37%
15,934
-1,316
-8% -$221K
RHT
43
DELISTED
Red Hat Inc
RHT
$2.46M 0.35%
13,104
-2,241
-15% -$414K
PPLI
44
People Inc
PPLI
$3.31B
$2.46M 0.35%
63,228
-5,970
-9% -$238K
XLNX
45
DELISTED
Xilinx Inc
XLNX
$2.46M 0.35%
20,851
-2,431
-10% -$283K
SCHZ icon
46
Schwab US Aggregate Bond ETF
SCHZ
$10.6B
$2.42M 0.34%
91,330
+6,832
+8% +$178K
APC
47
DELISTED
Anadarko Petroleum
APC
$2.4M 0.34%
+33,972
New +$2.28M
GILD icon
48
Gilead Sciences
GILD
$167B
$2.35M 0.33%
34,731
+3,179
+10% +$209K
PFE icon
49
Pfizer
PFE
$143B
$2.18M 0.31%
52,993
-173
-0.3% -$6.87K
XHE icon
50
State Street SPDR S&P Health Care Equipment ETF
XHE
$151M
$2.17M 0.3%
+26,480
New +$2.07M

Similar funds

Aptus Capital Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Aptus Capital Advisors held 372 positions worth $711M, up 21% from $585M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Aptus Capital Advisors deployed $103M of net new capital in Q2 2019, opening 65 new positions and adding to 147 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 18,822 shares worth $5.07M.

By sector, the portfolio is most concentrated in Technology at 6% of assets, down from 8.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Hartford Multifactor Developed Markets ex-US ETF, an estimated $2.14M trimmed.

  • Aptus Capital Advisors's largest Q2 2019 buy was Vanguard S&P 500 ETF: 18,822 shares worth $5.07M.
  • Aptus Capital Advisors added most to Aptus Defined Risk ETF in Q2 2019, an estimated $29.5M increase.
  • Aptus Capital Advisors's biggest Q2 2019 reduction was Hartford Multifactor Developed Markets ex-US ETF, cutting an estimated $2.14M.
  • Aptus Capital Advisors fully exited Waters Corp in Q2 2019, selling an estimated $2.96M.
  • Aptus Capital Advisors's ten largest holdings make up 45% of its $711M portfolio in Q2 2019.
  • Aptus Capital Advisors opened 65 new positions and closed 43 in Q2 2019.
  • Aptus Capital Advisors's portfolio value rose 21% quarter-over-quarter to $711M.

Based on Aptus Capital Advisors's 13F filing for Q2 2019, filed 13 Aug 2019.